Europe’s medical devices industry saw a drop of 15.38% in cross border deal activity during September 2022, when compared with the last 12-month average, led by DCC Healthcare’s $243.32m acquisition of Medi-Globe, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 22 medical devices industry cross border deals worth $400.9m were announced for the region in September 2022, against the 12-month average of 26 deals.

Of all the deal types, venture financing saw most activity in September 2022 with 13 transactions, representing a 59.1% share for the region.

In second place was M&A with eight deals, followed by private equity deals with one transactions, respectively capturing a 36.4% and 4.6% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, M&A was the leading category in Europe’s medical devices industry with $243.32m, followed by venture financing deals totalled $157.54m.

Europe medical devices industry cross border deals in September 2022: Top deals

The top five medical devices cross border deals accounted for 88.2% of the overall value during September 2022.

The combined value of the top five medical devices cross border deals stood at $353.4m, against the overall value of $400.9m recorded for the month.

The top five medical devices industry cross border deals of September 2022 tracked by GlobalData were:

1) DCC Healthcare’s $243.32m acquisition deal with Medi-Globe

2) The $46.94m venture financing of TRiCares by 415 Capital Management, Andera Partners, BioMedPartners, Credit Mutuel Innovation, Go Capital , Karista and Wellington Partners Venture Capital

3) AXA Venture Partners, Bpifrance Financement, Karista, LBO France and Wille Finance’s $27.03m venture financing deal with Incepto Medical

4) The $20m venture financing of Your.MD by Canica, Orkla Ventures, Reckitt Benckiser Group and Smedvig Capital

5) General Catalyst Partners, Giant Ventures Global, KHP Ventures and SpeedInvest’s $16.11m venture financing deal with Doccla